drugset / Trial / NCT02182791

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women

NCT02182791

Phase 1 Completed 14 enrolled Boehringer Ingelheim
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Study to determine the effects of nevirapine treatment on the pharmacokinetics of ethinyl estradiol (EE)/norethindrone (NET).

Timeline

Start
1998-04
Primary completion
1999-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule
Comparator Norethindrone Unknown
Comparator ethinyl estradiol Small molecule